Skip to main content

Basel Medical Group Ltd

BMGL
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
SEC CIK
0002004489

No open-market purchases or sales by Basel Medical Group Ltd insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $3.44K in total; no superinvestor holds it.

13F holders, Q4 2025

Institutional positions in Basel Medical Group Ltd as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
10
0 vs. Q3 2025
Shares held
143.3K
−146.3K (−50.5%) vs. Q3 2025
Total value
$70.2K
−$454.4K (−86.6%) vs. Q3 2025
New holders
6
1 more added
Sold out
6
1 more reduced

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BMGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 10 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 6 institutionsQ3 2025: 10 institutionsQ4 2025: 10 institutionsQ1 2026: 4 institutionsQ2 2026: 2 institutions
Value heldQ4 2025: $70.2K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $221.2KQ3 2025: $524.6KQ4 2025: $70.2KQ1 2026: $32.2KQ2 2026: $3.44K
Institutions holding BMGL and their total value by quarter
QuarterHoldersValue
Q2 20262$3.44K
Q1 20264$32.2K
Q4 202510$70.2K
Q3 202510$524.6K
Q2 20256$221.2K
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Basel Medical Group Ltd; share changes are against Q3 2025.

Institutions holding BMGL in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Coston, McIsaac & Partners50$00.00%00.0%Unchanged
Citigroup Inc1$00.00%+1New
Bell Investment Advisors, Inc248$1220.00%00.0%Unchanged
UBS Group AG8,089$3.96K0.00%+2,190+37.1%Added
Renaissance Technologies LLC14,498$7.10K0.00%+14,498New
Susquehanna International Group, LLP15,290$7.49K0.00%+15,290New
Jane Street Group, LLC16,288$7.98K0.00%+16,288New
Citadel Advisors LLC24,672$12.1K0.00%−68,325−73.5%Reduced
XTX Topco Ltd30,430$14.9K0.00%+30,430New
Ground Swell Capital, LLC33,705$16.5K0.03%+33,705New
Morgan Stanley0$00.00%−74,292−100.0%Sold out
Marex Group plc0$00.00%−58,913−100.0%Sold out
Virtu Financial LLC0$00.00%−33,786−100.0%Sold out
JustInvest LLC0$00.00%−22,107−100.0%Sold out
WealthCollab, LLC0$00.00%−953−100.0%Sold out
EverSource Wealth Advisors, LLC0$00.00%−277−100.0%Sold out